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Abstract
Setting: Hawassa, Southern Region of Ethiopia.
Objectives: To determine compliance to isoniazid (INH) preventive therapy (IPT) and its effectiveness in preventing (TB)
disease in children in contact with adults with pulmonary TB (PTB).
Design: This was a prospective cohort study of children ,15 years old in contact with adults with smear-positive PTB.
Asymptomatic children #5 years were provided IPT independently of their Tuberculin Skin Test (TST) status and children .5
years old were given advice but did not receive IPT, as recommended by the National TB control programme. Compliance to
IPT and incidence of clinical TB were determined monthly for six months and then quarterly for up to 30 months.
Results: One hundred and eighty four children in contact with 83 smear-positive PTB cases were identified. Eighty two were
#5 and 102.5 years old. Only 27 (33%) of 82 children given IPT took it for .4 months and 10 (12%) completed the 6-month
course. The main reason for non-compliance was the perception that drugs were not necessary when the child was healthy.
Eleven children (all except one .5 years old) developed symptoms of TB disease and initiated treatment, resulting in an
incidence of 28.6 cases for all and 53.5 for children .5 years old per 1000 children-year.
Conclusion: Compliance to IPT in children is poor in Southern Region of Ethiopia and this was associated with the parents’
perception of the low importance of chemoprophylaxis in asymptomatic children. Poor compliance might be an important
barrier for the wider implementation of IPT.
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Introduction
Tuberculosis (TB) is one of the leading causes of morbidity and
mortality globally (WHO, 2009) and children are estimated to
represent between 13% and 15% of cases in high TB burden
countries (HBC) [1]. TB is one of the five major causes of death in
Ethiopia (WHO, 2006) and in the Southern Nations, Nationalities
and People’s Region (SNNPR) childhood TB represents 7.7% of
new smear-positive and 13% of all forms of TB reported [2].
Young children have a high risk of TB infection and disease
progression because of their intimate contact with adults with
pulmonary TB (PTB) [3] and immature immune system [4]. Isoniazid
(INH) Preventive Therapy (IPT) has been shown to prevent new
infections and inhibit progression from infection to TB disease and in
HBCIPTcanreducetheincidenceby around40%among Tuberculin
Skin Test (TST)-positive individuals [5]. It is thus recommended that
children ,5 years old in contact with adults with smear-positive PTB
are screened for tuberculosis disease, and if no disease is found, offered
IPT [6]. TB control programmes however rarely have the resources
and manpower for implementation and several studies have reported
that adherence to IPT is generally poor [7,8,9].
There is no information on patterns of adherence to IPT and
the incidence of TB among children in contact with adults with
PTB in Ethiopia. This study therefore aimed to determine the level
of IPT adherence of children in contact with adults with smear-
positive PTB in the SNNPR and the incidence of TB among
children receiving and not receiving IPT.
Methods
The study was approved by the SNNPR Health Bureau, the
Research Ethics Committees of Hawassa University and the
Liverpool School of Tropical Medicine and the National Ethics
Review Council of Ethiopia.
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SNNPR, one of the largest regions of the country with over 15
million population. Consecutive adults diagnosed as having smear-
positive PTB and who lived with children ,15 years old were
invited to participate when attending Bushullo Major, Hawassa
Health centre and Hawassa University Hospital in Hawassa, the
capital of the SNNPR. After obtaining informed consent, families
were visited to document demographic and socio-economic
characteristics of the family and enter the household location into
a Geographical Positioning System to facilitate the identification of
households during the follow up. All children were examined and
laboratory tests were conducted as needed to exclude TB disease.
Three children had symptoms compatible with TB and were
referred for diagnosis. These children were then diagnosed as
having TB, treated with anti-TB drugs and excluded from the
cohort presented here. As part of the cohort study, TST was
applied to all asymptomatic children to describe the natural course
of potential markers of infection over time (including TST,
Interferon-c and IP10 and others, data not shown). TST was
applied with Purified Protein Derivative (Serum Statens Institute,
Denmark) equivalent to 2 International Units of Tuberculin on the
volar aspect of arm using the Mantoux method and according to
the manufacturer’s instructions and TST readings were obtained
48–72 hours later using the palpation method. TST indurations
were classified as negative (,5 mm), intermediate (5–9 mm) and
positive ($10 mm) [10]. Blood samples were collected and tested
in duplicate for HIV using two ELISA methods.
All children ,5 years old were provided INH (5 mg/kg/day)
for 6 months, independently of the TST results, while older
children underwent the same examinations and testing but were
not given IPT, according to the National TB Control
Programme guidelines [11]. All children were enrolled during
ap e r i o do fo n ey e a ra n df o l l o w e df o rb e t w e e n1 7a n d3 0m o n t h s
(the maximum duration of the study). Children were followed
monthly for the first 6 months and then every three months for
up to a maximum of 30 months. Parents were informed about
the need for IPT and to report any adverse effect, the
importance of adherence to treatment and to attend the study
clinics if the child developed symptoms of ill health suggestive of
TB between the visits. INH tablets were supplied free of charge
in blister packets during the monthly visits and parents were
asked whether their child had experienced adverse effects or
developed symptoms since the previous visit. IPT compliance
was assessed by asking parents if the child had taken the pills,
checking the blister packs and counting pills. Parents who had
not given the pills to the child were asked the reasons for the lack
of compliance, were reminded of the advantages of IPT, and
advised to resume the pills. IPT compliance was classified as
reasonable, poor or very poor (if taken for more than 4 months,
2t o4o r,2 months, respectively) [12]. Children with symptoms
compatible with TB were referred to a pediatrician for further
clinical, laboratory and radiological investigations and to initiate
treatment, as required.
Data were entered into an SPSS database and checked for
discordances after data cleaning. P values,0.05 were considered
statistically significant.
Results
One hundred and eighty four children in contact with 83
adults with smear-positive PTB were identified and followed
between October 1, 2007 and April 30, 2009. Of these, 88
(47.8%) were male and 36% resided in rural areas. On
enrolment their age ranged from 1 to 15 years and 82 (45%)
were ,5 years old. One hundred and six (58%) children had
positive, 22 (12%) intermediate and 56 (30%) negative TST. The
majority of children ,5 years old had negative or intermediate
TST, while most children .5 years old had positive TST, as
shown in table 1. Sixteen (10.8%) of 148 children tested for HIV
were positive.
The median follow up duration was 24 months with a range of
17 to 30 months. All parents of children ,5 years old agreed to
give IPT to their children. TST indurations of children with and
without IPT were different, with children receiving IPT having
smaller indurations than children not receiving IPT. On follow up,
there were no adverse effects reported among children receiving
IPT. Only 27 (32.9%) children had reasonable IPT compliance,
while 24 (29.3%) had poor and 31 (37.8%) very poor compliance.
Among children with reasonable compliance, only 10 (12.2% of
82) completed the 6-month IPT course. Thirty seven (67%) of 55
parents whose children had poor/very poor compliance indicated
the main reason for non-compliance was the perception that drugs
were not necessary when the child was healthy.
Eleven (6%) children were diagnosed as having TB disease
during the follow up period, resulting in an incidence of 28.6 cases
per 1000 person-years follow up for all children and 53.5 for
children age .5 years old. The characteristics of these 11 children
who developed TB disease are shown in table 2. Their mean age
Table 1. Characteristics of children who received and not received INH prophylaxis.
Characteristics on enrolment #5 years old (N=82) .5 years old (N=102)
Male (%): 39 (47.5) 50 (49)
Mean (SD) age (years): 2.9 (1.4) 9.9 (3)
Weight for height Z score ,23SD 5 (6.1) 1(0.9)
23SD to 22SD 3 (3.7) 10 (9.8)
.22SD 74 (90.2) 91 (89.3)
Contact time per day (mean (SD), hours) 11.6 (5.7) 8.1 (4.2)
TST result positive 38 (46%) 68 (67%)
intermediate 14 (17%) 26 (25%)
negative 30 (47%) 8 (8%)
BCG scar present, N (%): 52 (63.4) 58 (56.9)
N=number, SD, Standard deviation, mm=millimeter, TST=Tuberculin skin test.
doi:10.1371/journal.pone.0026452.t001
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who did not develop symptoms (p=0.9, not significant) and all but
one (91%) had a positive TST, compared to only 96 (55.5%) of
172 children without TB. Two children had smear-positive PTB,
seven were diagnosed as having smear-negative PTB and two had
cervical TB lymphadenitis. The median time from enrolment to
diagnosis of TB was 120 days (range 3 to 403 days). Children who
develop TB were less likely to live in households with windows and
none of them had received IPT, as shown in Table 3, although the
number of children with TB was small and the comparison needs
to be interpreted with caution.
Discussion
Children, and especially young children, in contact with adults
with PTB are at high risk of infection due to their intimate and
prolonged contact with adult index cases within the household.
The TST positivity rate among the children enrolled in our study
was high, but within the range reported from similar settings (e.g.
63% in Zimbabwe [13] and 49% in Nigeria [14]. The TST
positivity rate in children in contact with adults with TB was much
higher than the rate observed in children without known exposure
to TB in the same area (13%, [15]). Young children have a high
risk of progression from infection to disseminated disease because
their immunological system is unable to contain and localize the
bacilli, often resulting in severe forms of TB such as miliary TB
and meningitis. Nearly all TB Control programmes worldwide
recognize this increased risk and support the notion of providing
prophylaxis for young children.
Despite this awareness, guidelines are rarely implemented in
resource-poor settings due to a lack of resources. Reports of IPT
uptake and adherence are scarce and poorly documented, with only
a few scientific reports reporting IPT adherence in the last decade.
Within the African context, two studies in South Africa reported
that IPT adherence was 20% in a retrospective review of records
and 27.6% in a prospective cohort of children exposed to adults
with PTB [9,12]. In Malawi, only 17% of children participating in a
cohort with passive follow up completed 6 months of IPT compared
to 22% for children with active follow up [16]. These findings
suggest that the low IPT adherence observed in our study is unlikely
to be unusual and that further studies are needed to identify
approaches that facilitate adherence in the African continent.
The most frequent reason for the poor adherence was that
parents did not perceive IPT as an important method to reduce
the risk of disease progression in the absence of symptoms. The
same reasoning was reported in South Africa [12], suggesting that
interventions to increase adherence need to address the popula-
tion’s perception that drugs are not needed for asymptomatic
individuals. Key factors to ensure the success of IPT programmes
therefore are to make the drugs and the services available
regularly, a better understanding of the parents’ perception of the
risk of disease after exposure, their awareness of the importance of
adherence in the absence of symptoms, the development of
Table 2. Characteristics of children who developed tuberculosis disease (N=11).
Age* (years) Sex TST (mm) HIV BCG scar
Adult smear
grade Window** Treatment outcome Presentation
2 Male 22 Neg Yes 1+ No Completed SS
2PTB
6 Female 19 Neg Yes 1+ No Completed EPTB
6 Female 19 Neg No scanty No Completed EPTB
6 Male 6 Neg Yes 2+ No Completed SS
+PTB
7 Male 18 Neg Yes 1+ No Completed SS
2PTB
10 Female 13 Neg Yes 2+ No Completed SS
2PTB
10 Male 21 NA Yes 1+ No Completed SS
2PTB
12 Male 21 Neg Yes 1+ Yes Completed SS
2PTB
14 Female 19 Neg Yes 1+ No On treatment SS
+PTB
14 Male 19 Neg Yes 1+ Yes Completed SS2PTB
14 Male 19 Neg Yes 1+ No Completed SS
2PTB
*At the time of enrolment.
**Presence of windows in the home; NA=Not available. EPTB=Extrapulmonary TB, SS+ PTB=Smear positive pulmonary TB, SS2 PTB=Smear negative pulmonary TB,
Neg=negative, TST=Tuberculin skin test.
doi:10.1371/journal.pone.0026452.t002
Table 3. Characteristics of children with and without TB




Male 7 (64%) 81(47%) 0.3
Mean (SD) age
(enrolment)
9.2 (4%) 6.7 (4%) 0.9
TST* (mm) Positive 10 (92%) 96 (56%) 0.02
Intermediate 1 (9%) 56 (32%)
Negative 0 (0%) 21 (12%)
HIV Positive 0 (0%) 16 (9%) 0.3
Negative 10 (91%) 122 (71%)
Unknown 1 (9%) 35 (20%)
Smear grade of the adult*
Scanty 1 (9%) 3 (2%) 0.15
+ 8 (73%) 115 (67%)
++ 2 (18%) 41 (24%)
+++ 0 (0%) 14 (8%)
Home has windows 2 (18%) 119 (69%) 0.001
*Chi square for trend, N=number, TB=tuberculosis, mm=millimeter,
SD=Standard deviation.
doi:10.1371/journal.pone.0026452.t003
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messages and addressing the concerns of health staff in the
community.
A significant proportion of children in the study were HIV-
positive. The risk of disease progression in general is highest in
immunocompromised children with HIV co-infection and studies
to document the effectiveness and scaling-up feasibility of IPT in
HIV-infected individuals are currently under way. IPT however is
already recommended for HIV-infected individuals in many
countries and understanding its acceptability and likely adherence
under operational conditions, and the parents and staff perception
of the need of IPT and risk of drug resistance, together with a
description of the constraints faced by health systems would be
important to facilitate implementation.
None of the children receiving IPT developed TB disease, while
6% of older children not receiving IPT were diagnosed with TB
disease during the follow up period, although only a small
proportion of them were microbiologically confirmed. None of the
children who developed TB disease were co-infected with HIV,
suggesting that the risk of disease progression in older children is
not negligible even without HIV co-infection. The estimated
incidence of all forms of TB in the general population in Ethiopia
in 2009 was 359 per 100,000 [17] and the incidence of TB disease
among the children followed (28.6 per 1000 children-year) was
very high. This finding highlights the need for contact investiga-
tion and providing IPT and allocating adequate resources to
prevent TB in contacts of infectious TB cases. Although for
operational and resource constrains older children are often
excluded, IPT may be of benefit for this age group in high TB
incidence settings.
This study therefore illustrates that compliance to IPT in young
children is poor in Southern Region of Ethiopia and that the lack
of compliance is associated with the parents’ perception of the
importance of chemoprophylaxis. The reluctance of parents to
resume IPT after counseling indicates that this might be an
important barrier for its wider implementation and further studies
are needed to develop communication strategies to effectively
convey these messages.
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